ARISAPH PHARMACEUTICALS, INC.
| 100 HIGH STREET
BOSTON, MA, 02110-2321
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|
DESCRIPTION (provided by applicant): In the United States, around 76,250 new cases of melanoma and 9,180 melanoma-related deaths are predicted for 2012. With the therapeutic options currently availabl ...STTR Phase I 2013 Department of Health and Human Services
DESCRIPTION (provided by applicant): In the United States colorectal cancer (CRC) is the third leading cause of cancer mortality. Surgery is the primary treatment for early stage CRC; but adjuvant the ...STTR Phase I 2012 Department of Health and Human Services
DESCRIPTION (provided by applicant): Cancer is America's second leading cause of death. Many approved cancer drugs, such as bortezomib (Velcade), are cytotoxic agents that kill normal cells as we ...STTR Phase I 2011 Department of Health and Human Services